Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
The Journal of Pathology|July 21, 2017
Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndromeHans Binder, Lydia Hopp, Michal R Schweiger, et al.The Journal of Clinical Investigation|September 11, 2025
Targeting peroxiredoxin 2 prevents hepatocarcinogenesis in metabolic liver disease modelsEmilie Crouchet, Eugénie Schaeffer, Marine A Oudot, et al.Egastroenterology|March 24, 2025
Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver diseaseArmando Andres Roca Suarez, Frank Jühling, Julien Moehlin, et al.Gut|March 29, 2020
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinomaFrank Jühling, Nourdine Hamdane, Emilie Crouchet, et al.Nature Communications|August 29, 2024
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infectionAtish Mukherji, Frank Jühling, Yogy Simanjuntak, et al.Gastroenterology|March 6, 2019
HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic ResponseNourdine Hamdane, Frank Jühling, Emilie Crouchet, et al.Science Translational Medicine|June 3, 2026
Claudin-1 targeting suppresses tumor growth, invasion, and metastasis in patient-derived cholangiocarcinoma modelsZeina Nehme, Marion Muller, Jade Brochon, et al.Nature Communications|February 19, 2025
A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer developmentAnne T Schneider, Christiane Koppe, Emilie Crouchet, et al.Gastroenterology|April 13, 2019
Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease DevelopmentJoachim Lupberger, Tom Croonenborghs, Armando Andres Roca Suarez, et al.Journal of Hepatology|October 29, 2022
Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironmentNatascha Roehlen, Marion Muller, Zeina Nehme, et al.Pageof 5